25.50
                                            전일 마감가:
              $24.66
            열려 있는:
              $24.36
            하루 거래량:
                552.33K
            Relative Volume:
              1.13
            시가총액:
                $1.19B
            수익:
              $722.68M
            순이익/손실:
              $134.71M
            주가수익비율:
              9.5506
            EPS:
                2.67
            순현금흐름:
                $109.94M
            1주 성능:
              +4.00%
            1개월 성능:
              -4.32%
            6개월 성능:
                +4.47%
            1년 성능:
              -49.53%
            Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
명칭
                  
                      Amphastar Pharmaceuticals Inc
                    
                전화
                  
                      909-980-9484
                    
                주소
                  
                      11570 SIXTH STREET, RANCHO CUCAMONGA, CA
                    
                AMPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 | 
|---|---|---|---|---|---|---|
|   
                          
                                AMPH
                            
                             Amphastar Pharmaceuticals Inc | 25.50 | 1.15B | 722.68M | 134.71M | 109.94M | 2.67 | 
|   
                          
                                ZTS
                            
                             Zoetis Inc | 144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 | 
|   
                          
                                TAK
                            
                             Takeda Pharmaceutical Co Adr | 13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 | 
|   
                          
                                HLN
                            
                             Haleon Plc Adr | 9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 | 
|   
                          
                                TEVA
                            
                             Teva Pharmaceutical Industries Ltd Adr | 20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 | 
|   
                          
                                UTHR
                            
                             United Therapeutics Corp | 445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 | 
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 | 
|---|---|---|---|
| 2025-08-12 | 업그레이드 | Needham | Hold → Buy | 
| 2025-05-12 | 다운그레이드 | JP Morgan | Overweight → Neutral | 
| 2025-02-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral | 
| 2024-11-22 | 개시 | Wells Fargo | Equal Weight | 
| 2024-03-05 | 개시 | JP Morgan | Overweight | 
| 2023-11-17 | 개시 | BofA Securities | Neutral | 
| 2023-07-25 | 재개 | Jefferies | Buy | 
| 2022-10-21 | 재개 | Jefferies | Buy | 
| 2022-07-29 | 개시 | CapitalOne | Overweight | 
| 2022-01-07 | 업그레이드 | Piper Sandler | Neutral → Overweight | 
| 2021-01-08 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight | 
| 2020-10-05 | 업그레이드 | Northland Capital | Market Perform → Outperform | 
| 2020-05-01 | 개시 | Northland Capital | Outperform | 
| 2019-03-13 | 다운그레이드 | Needham | Buy → Hold | 
| 2019-03-13 | 다운그레이드 | Piper Jaffray | Overweight → Neutral | 
| 2018-08-10 | 재확인 | Needham | Buy | 
| 2018-03-13 | 재확인 | Needham | Buy | 
| 2017-12-01 | 재확인 | Needham | Buy | 
| 2017-11-09 | 다운그레이드 | Raymond James | Outperform → Mkt Perform | 
| 2017-09-27 | 재확인 | Needham | Buy | 
| 2017-03-14 | 다운그레이드 | Raymond James | Strong Buy → Outperform | 
| 2016-08-09 | 재확인 | Needham | Buy | 
| 2016-05-10 | 재확인 | Needham | Buy | 
| 2016-02-19 | 개시 | Wells Fargo | Outperform | 
| 2015-06-19 | 재확인 | Needham | Buy | 
| 2015-06-03 | 개시 | Raymond James | Strong Buy | 
| 2014-07-21 | 개시 | Needham | Buy | 
                    모두보기
                     
                  
                Amphastar Pharmaceuticals Inc 주식(AMPH)의 최신 뉴스
Why Amphastar Pharmaceuticals Inc. (29A) stock could be next leaderQuarterly Profit Review & Proven Capital Preservation Tips - newser.com
Will Amphastar Pharmaceuticals Inc. stock deliver shareholder valueJuly 2025 Retail & Capital Efficiency Focused Ideas - newser.com
Real time scanner hits for Amphastar Pharmaceuticals Inc. explainedWeekly Market Report & AI Forecasted Entry/Exit Points - newser.com
Analyzing recovery setups for Amphastar Pharmaceuticals Inc. investorsJuly 2025 Price Swings & Free Expert Approved Momentum Trade Ideas - newser.com
Using Python tools to backtest Amphastar Pharmaceuticals Inc. strategiesInsider Selling & Real-Time Stock Movement Alerts - newser.com
Will Amphastar Pharmaceuticals Inc. (29A) stock outperform energy sector in 2025July 2025 Decliners & Target Return Focused Picks - newser.com
Can trapped investors hope for a rebound in Amphastar Pharmaceuticals Inc.Portfolio Update Summary & Reliable Intraday Trade Plans - newser.com
Key metrics from Amphastar Pharmaceuticals Inc.’s quarterly dataShare Buyback & AI Powered Market Entry Strategies - newser.com
Why Amphastar Pharmaceuticals Inc. stock remains resilientJuly 2025 Institutional & Accurate Technical Buy Alerts - newser.com
Can Amphastar Pharmaceuticals Inc. stock maintain growth trajectoryQuarterly Market Summary & Free High Accuracy Swing Entry Alerts - newser.com
Should you wait for a breakout in Amphastar Pharmaceuticals Inc.2025 Stock Rankings & Daily Entry Point Trade Alerts - newser.com
Can Amphastar Pharmaceuticals Inc. stock hit analyst price targetsProduct Launch & Fast Entry Momentum Alerts - newser.com
Applying Elliott Wave Theory to Amphastar Pharmaceuticals Inc.2025 Performance Recap & AI Forecast Swing Trade Picks - newser.com
How Amphastar’s New BAQSIMI Distribution Pact in Greater China Could Impact AMPH Investors - Yahoo Finance
Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Is Amphastar Pharmaceuticals Inc. (29A) stock trading at attractive multiplesJuly 2025 Catalysts & Community Verified Swing Trade Signals - newser.com
What momentum shifts mean for Amphastar Pharmaceuticals Inc.Weekly Profit Summary & AI Optimized Trade Strategies - newser.com
Amphastar Pharmaceuticals (AMPH) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Multi asset correlation models including Amphastar Pharmaceuticals Inc.Dollar Strength & Weekly Top Performers Watchlists - newser.com
Is Amphastar Pharmaceuticals Inc. (29A) stock a buy for dividend portfoliosPortfolio Return Report & Low Risk High Win Rate Picks - newser.com
United States Anaphylaxis Treatment Market 2025: Industry - openPR.com
Why Amphastar Pharmaceuticals Inc. stock attracts high net worth investorsWatch List & Safe Entry Trade Reports - Fundação Cultural do Pará
Amphastar Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
AlphaQuest LLC Acquires 17,289 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Will Amphastar Pharmaceuticals Inc. (29A) stock beat international competitionWeekly Loss Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Amphastar Pharmaceuticals Inc (AMPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
                자본화:
                 
                  | 
                볼륨(24시간):
                 
            
         
                     
                             Stockscreener 앱 받기
                    Stockscreener 앱 받기